Bristol-Myers Squibb Company (BMY) vs Thermo Fisher Scientific Inc. (TMO)
BMY leads on 13 of 16 compared metrics.
A side-by-side comparison of Bristol-Myers Squibb Company and Thermo Fisher Scientific Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 15, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
BMY
Bristol-Myers Squibb Company
$57.13Healthcare
TMO
Thermo Fisher Scientific Inc.
$469.34Healthcare
Total return — BMY vs TMO
growth of $100 · last 30yBMY +168.8%TMO +1191.9%TMO compounded faster
BMY TMO
BMY vs TMO: by the numbers
- •TMO is the larger company ($174.42B vs $116.66B market cap).
- •BMY trades at the lower earnings multiple (16.05 vs 25.80 P/E).
- •TMO converts more revenue to profit (15.18% vs 15.01% net margin).
- •TMO grew revenue faster over the past five years (6.68% vs 2.52% CAGR).
- •BMY pays the higher dividend yield (4.38% vs 0.38%).
Which is better, BMY or TMO?
Metric tally: BMY 13 · TMO 3It depends on what you're optimizing for:
ValueBMY(lower P/E)
GrowthTMO(faster 5Y revenue CAGR)
IncomeBMY(higher dividend yield)
QualityBMY(higher ROIC)
Metrics side by side
Valuation
| Metric | BMY | TMO |
|---|---|---|
| P/E ratio | 16.05● | 25.80 |
| Forward P/E | 9.31● | 17.26 |
| P/S ratio | 2.41● | 3.87 |
| P/B ratio | 5.82 | 3.37● |
| PEG ratio | 1.71● | 4.51 |
| EV / EBITDA | 11.03● | 19.26 |
| FCF yield | 10.20%● | 3.86% |
Profitability
| Metric | BMY | TMO |
|---|---|---|
| Gross margin | 68.75%● | 39.41% |
| Operating margin | 25.67%● | 17.76% |
| Net margin | 15.01% | 15.18% |
| ROE | 36.25%● | 13.21% |
| ROIC | 13.90%● | 7.58% |
Dividends
| Metric | BMY | TMO |
|---|---|---|
| Dividend yield | 4.38%● | 0.38% |
| Payout ratio | 72.25% | 10.13% |
Growth (annualized)
| Metric | BMY | TMO |
|---|---|---|
| Revenue CAGR (5Y) | 2.52% | 6.68%● |
| EPS CAGR (5Y) | 9.38%● | 1.99% |
| FCF CAGR (5Y) | -2.50% | -0.19%● |
| Total return CAGR (5Y) | 0.74%● | 0.45% |
Frequently asked
- Which is better, BMY or TMO?
- It depends on your goal. value: BMY (lower P/E); growth: TMO (faster 5Y revenue CAGR); income: BMY (higher dividend yield); quality: BMY (higher ROIC). Across all compared metrics, BMY leads 13 to 3.
- Is BMY or TMO cheaper?
- On trailing earnings, BMY is cheaper: BMY trades at a 16.05 P/E and TMO at 25.80.
- Which has grown faster, BMY or TMO?
- Over the past five years, TMO grew revenue faster — BMY at a 2.52% CAGR versus TMO at 6.68%.
- Does BMY or TMO pay a bigger dividend?
- BMY yields 4.38% and TMO yields 0.38% based on trailing dividends and the latest price.
- Is BMY or TMO more profitable?
- TMO runs the higher net margin — BMY at 15.01% versus TMO at 15.18%.
- Which has been the better investment, BMY or TMO?
- Over the past 10-year, TMO delivered the higher annualized total return — BMY at 1.08% versus TMO at 12.26%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Bristol-Myers Squibb P/E ratioThermo Fisher Scientific P/E ratioBristol-Myers Squibb dividend yieldThermo Fisher Scientific dividend yieldBristol-Myers Squibb ROEThermo Fisher Scientific ROEBristol-Myers Squibb operating marginThermo Fisher Scientific operating marginBristol-Myers Squibb revenue growthThermo Fisher Scientific revenue growthBristol-Myers Squibb free cash flowThermo Fisher Scientific free cash flow
Bristol-Myers Squibb & Thermo Fisher Scientific appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 15, 2026.